eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-TRVI-Trevi Therapeutics Inc

Trevi Therapeutics Inc TRVI

‎$‎10.47-0.22(-2.06%)(1D)
• Delayed prices by NASDAQ • in USD
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Strong Buy
Price Target
22.80
Based on analysts who covered TRVI
Invest in Trevi Therapeutics Inc
Today
Create an eToro account to buy TRVI stock on a secure, user-friendly, multi-asset trading platform.
Buy Trevi Therapeutics Inc
Trevi Therapeutics Inc TRVI
Buy TRVI

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

TRVI Stock Price Chart

‎-17.82‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered by
*Past performance is not an indication of future results
Asset positive trend

The Trevi Therapeutics Inc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Trevi Therapeutics Inc share price today is ‎$‎10.47, reflecting a ‎-2.06‎% change over the last 24 hours and ‎4.91‎% over the past week. The current market capitalization of TRVI is ‎$‎1.34B with an average volume in the last three months of 1.83M. The stock has a P/E ratio of -28.2 and a dividend yield of 0%. With the stock’s beta sitting at 0.73
TRVI Key Metrics
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
‎$‎1.34B
Day’s Range
i
Shows the high and low prices of the day.
‎$‎10.24 - ‎$‎10.72
52W Range
i
Shows the high and low prices of the last year.
‎$‎9.8 - ‎$‎12.98
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
1.83M
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-28.2
Revenue
i
The total income generated by this company’s goods and services last year.
‎$‎0
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
‎$‎0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎10.47
EPS
i
A company’s total earnings divided by the number of shares it has issued.
‎$‎-0.37
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.73

How can I buy Trevi Therapeutics Inc stocks?

To purchase Trevi Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Trevi Therapeutics Inc (TRVI) page and place an order to buy Trevi Therapeutics Inc.
Buy TRVI
Looking for more information? Check out our guide on Academy.
What Is Trevi Therapeutics Inc?
Trevi Therapeutics Inc is a US‑based clinical-stage biopharmaceutical company dedicated to developing innovative therapies. Its primary aim is to address unmet medical needs in patients suffering from neurological and psychiatric disorders, focusing on chronic pruritus and cough. The company strives to improve patient quality of life.

Operating within the biotechnology and pharmaceutical sector, Trevi Therapeutics Inc specialises in developing treatments for chronic conditions. Its specific approach involves advancing Haduvio (nalbuphine ER) as a potential solution to reduce severe symptoms and provide long-term relief for patients.

Keep up to date on the latest share price changes by adding TRVI stock to your eToro watchlist.

This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.
NASDAQ
Get Started
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2026
Top Dividend Stocks for 2026
Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.
Read More
AI Stocks Poised for Growth in 2026
AI Stocks Poised for Growth in 2026
Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Trevi Therapeutics Inc
Invest in Trevi Therapeutics Inc
Today
Create an eToro account to buy TRVI stock on a secure, user-friendly, multi-asset trading platform.
Get Started

FAQ

The current price of TRVI is ‎$‎10.47.
The average price target for Trevi Therapeutics Inc is ‎$‎22.80. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Trevi Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Trevi Therapeutics Inc is ‎$‎1.34B
Based on 5 analysts offering recommendations for TRVI in the last 3 months, the overall consensus is Strong Buy.
Daily Movers
Explore the biggest stocks movers on the market.
Buy TRVI
English (UK)English (UK)Check icon
DeutschDeutsch
FrançaisFrançais
PolskiPolski
PortuguêsPortuguês
DanskDansk
SuomiSuomi
EspañolEspañol
РусскийРусский
العربيةالعربية
NederlandsNederlands
SvenskaSvenska
RomânăRomână
ItalianoItaliano
中文中文
繁體中文繁體中文
NorskNorsk
ČeštinaČeština
Tiếng ViệtTiếng Việt
ΕλληνικάΕλληνικά
Scroll to top